» Authors » Arb-Aroon Lertkhachonsuk

Arb-Aroon Lertkhachonsuk

Explore the profile of Arb-Aroon Lertkhachonsuk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 152
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bualoy W, Sumdaengrit B, Junda T, Lertkhachonsuk A
Healthcare (Basel) . 2025 Jan; 13(2). PMID: 39857139
Background: Sexual satisfaction is vital for the sexual health and well-being of both cervical cancer patients and their spouses. Sexual dissatisfaction can arise from negative treatment, making it important to...
2.
Surasartpisal B, Tharawan K, Kuldejchaichan K, Lertkhachonsuk A
Med Teach . 2024 Jun; 47(4):684-695. PMID: 38913809
Purpose: In Thailand, Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) individuals face significant health disparities and discrimination in healthcare. A primary cause is the lack of knowledge among doctors and...
3.
Thephamongkhol K, Korpraphong P, Muangsomboon K, Sitathanee C, Lertkhachonsuk A, Phongkitkarun S, et al.
Sci Rep . 2022 Jun; 12(1):9873. PMID: 35701437
Study Design: Retrospective cohort. Participants: Locally advanced cervical cancer underwent concurrent chemoradiotherapy. Sample Size: 397 and 384 patients in the development and validation data set. Predictors: Our new nodal staging...
4.
Thephamongkhol K, Korpraphong P, Muangsomboon K, Sitathanee C, Lertkhachonsuk A, Phongkitkarun S, et al.
Curr Probl Cancer . 2022 Jun; 46(4):100876. PMID: 35687966
To evaluate and validate the minor lymphatic pathway for distant metastases in cervical cancer. This is a retrospective cohort of cervical cancer patients underwent curative concurrent chemoradiotherapy. We used original...
5.
Kongsawatvorakul C, Charakorn C, Chittithaworn S, Lertkhachonsuk A
J Obstet Gynaecol . 2022 Apr; 42(6):2331-2335. PMID: 35470751
The aim of treatment in recurrent or refractory epithelial ovarian cancer is palliation. In a patient with platinum-resistant status, several chemotherapy regimens have been reported with similar response rates. Among...
6.
Lertkhachonsuk A, Charoenkwan K, Wilailak S, Kasemsarn P, Srisomboon J
J Gynecol Oncol . 2022 Feb; 33(2):e36. PMID: 35128862
No abstract available.
7.
Chantasartrassamee P, Kongsawatvorakul C, Rermluk N, Charakorn C, Wattanayingcharoenchai R, Lertkhachonsuk A
Eur J Obstet Gynecol Reprod Biol . 2022 Jan; 270:176-180. PMID: 35074691
Objectives: To determine the preoperative clinical characteristics associated with uterine sarcoma in patients with uterine mass. Study Design: We retrospectively reviewed medical records of patients who presented with uterine mass...
8.
Chukasemrat N, Charakorn C, Lertkhachonsuk A
Evid Based Complement Alternat Med . 2021 Nov; 2021:1322390. PMID: 34804172
Background: To determine the factors influencing the use of complementary and alternative medicine (CAM) in gynecologic cancer patients and the prevalence and pattern of CAM use. Methods: This was a...
9.
Shiao M, Chang J, Lertkhachonsuk A, Rermluk N, Jinawath N
Biomedicines . 2021 Oct; 9(10). PMID: 34680550
Failure to detect early-stage epithelial ovarian cancer (EOC) is a major contributing factor to its low survival rate. Increasing evidence suggests that different subtypes of EOC may behave as distinct...
10.
Mathaveechotikul P, Charakorn C, Lertkhachonsuk A, Lekskul N, Wilailak S, Nagaviroj K
Ann Palliat Med . 2021 Aug; 10(10):10293-10312. PMID: 34412494
Background: Palliative care evidently increases the quality of life among the patients with advanced cancer. However, there are very few studies on the aspects of the physicians' ideas, conceptions, or...